Ovid Therapeutics Inc.
OVID· Nasdaq
Released Jun 13, 2017, after the close
10-Q filed Jun 13, 2017, 74 days after period end · 0001193125-17-202470
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 |
|---|---|---|
| Net Income | -$34.24M | -$3.68M |
| EPS Diluted | -$3.48 | -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed Jun 13, 2017 · 74 d after period end